Home / Inspections / 1244354

FDA Inspection 1244354 — Brigham And Women's Hospital

Brigham And Women's Hospital — FEI 1270016

The FDA completed an inspection of Brigham And Women's Hospital on June 12, 2024 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 12, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Boston, MA (United States)

Facility

Other inspections at this facility

  • 1148014 (NAI Wed Jul 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1103194 (VAI Thu Sep 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1019087 (NAI Fri Jun 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 926547 (NAI Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 868904 (NAI Thu Mar 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources